Sayama, Japan

Hiroshi Ninomiya


Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 267(Granted Patents)


Location History:

  • Sayama, JA (1977)
  • Sayama, JP (1979 - 1990)
  • Saitama, JP (1995)

Company Filing History:


Years Active: 1977-1995

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Hiroshi Ninomiya: A Pioneer in Pharmaceutical Innovations

Introduction

Hiroshi Ninomiya, based in Sayama, Japan, is a notable inventor with a substantial portfolio of 12 patents. His contributions to the field of pharmaceuticals have driven innovations that seek to enhance drug delivery systems and therapeutic efficacy.

Latest Patents

Among his latest inventions is a mucoadhesive polysiloxane paste-like base, which comprises a paste-like preparation of a polyorganosiloxane and a water-soluble polymeric material. This novel formulation, specified to be in a weight ratio from 3:6 to 6:3, incorporates an active ingredient, facilitating improved mucoadhesive properties. Another significant invention is a nitroglycerin spray, which involves a solution of nitroglycerin, ethanol, and water with a pH ranging from 2.4 to 6.7, designed to be stored in a liquid-pressurized container for effective medical use.

Career Highlights

Hiroshi has made impactful strides in his career by working with reputable organizations including Nippon Kayaku Kabushiki Kaisha and Dow Corning Corporation. His experiences at these companies have honed his expertise in chemical formulations and drug development.

Collaborations

Throughout his career, Hiroshi has had productive collaborations with esteemed colleagues such as Takashi Terada and Kooichi Yoshida. Their combined efforts have advanced the research and development of various innovative products in the pharmaceutical industry.

Conclusion

Hiroshi Ninomiya stands out as a significant figure in the realm of pharmaceutical inventions. His innovative patents reflect a deep understanding of materials and their applications in drug delivery, marking his contributions as essential to ongoing advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…